Read more

October 13, 2023
1 min read
Save

Top in allergy/asthma: FDA updates cross-contact guidelines; cat allergy lozenge

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The FDA has updated its draft guidance for preventing cross-contamination with major food allergens in manufacturing facilities and ensuring that finished products are properly labeled.

It was the top story in allergy/asthma last week.

PC1023AllergyListicle_13_Graphic_WEB
A pilot study showed that patients with cat allergies experienced improvements in their symptoms with twice-daily use of a holo beta-lactoglobulin lozenge for 3 months. Image: Adobe Stock

Another top story was about a lozenge that can improve symptoms in people with cat allergies.

Read these and more top stories in allergy/asthma below:

FDA updates draft guidance on allergen cross-contact for food manufacturers

The FDA has updated its draft guidance for preventing cross-contact between major food allergens in manufacturing facilities and ensuring that the ingredients in finished products are properly labeled. Read more.

Cat allergy symptoms improve with holo beta-lactoglobulin lozenges

Patients with cat allergies experienced improvements in their symptoms with twice-daily use of a holo beta-lactoglobulin lozenge for 3 months, according to a pilot study published in Clinical and Translational Allergy. Read more.

Q&A: Teal Pumpkin Project aims to make Halloween inclusive for kids with food allergies

For most families, Halloween is a fun night to dress up in costumes and eat a bunch of candy. But families of children with food allergies have to be cautious and inspect treats to avoid allergic reactions. Read more.

Maintenance therapy appears underused prior to asthma exacerbations

Many patients with moderate to severe asthma failed to use inhaled corticosteroids in addition to a short-acting beta 2 agonist as a rescue to prevent exacerbations, according to a study published in Annals of Allergy, Asthma & Immunology. Read more.

Honorees announced for second annual Healio Honors recognition program

Healio is pleased to announce and congratulate the 2023 honorees of its peer-to-peer recognition program, Healio Honors. Read more.